Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism.
Jiaying Hu, Leyan Zheng, Ziyu Guan...
https://pubmed.ncbi.nlm.nih.gov/37625524/Actively Recruiting
Led by Medical College of Wisconsin · Updated on 2026-06-16
20
Participants Needed
1
Research Sites
208 weeks
Total Duration
Researchers are investigating the effects of transcranial alternating current stimulation tACS and multisensory stimulation on verbal short-term memory STM in adults aged 45 and older with primary progressive aphasia PPA. This pilot project aims to understand whether these brain and sensory stimulation methods can influence language abilities and explore individual differences that might relate to disease progression. The study will provide foundational data to guide future clinical trials focused on predicting and possibly delaying PPA progression. Participants will receive high-definition tACS using a battery-operated device with electrodes placed at frontal and temporoparietal brain sites based on EEG localization. The stimulation will last 20 minutes with frequencies ranging from 4 to 40 Hz at 2 milliampere intensity. Sham tACS involves turning off the current after 30 seconds. Additionally, all participants will experience 20 minutes of light andor sound flicker stimulation through a mobile app. These interventions are delivered in multiple sessions to assess their effects. During the study, participants will undergo EEG and MRI scans, including anatomical and functional imaging. They may complete cognitive exams and language tasks before, during, and after stimulation sessions. The main outcome measured is changes in verbal STM capacity assessed through specific verbal STM tasks at various time points relative to stimulation. The study monitors participants over several sessions, tracking responses to both tACS and multisensory stimulation to better understand their impact on language function in PPA.
CONDITIONS
Stimulating the Aging Brain Using Brain and Sensory Stimulation
S
Sidney Schoenrock, MA
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Medical College of Wisconsin
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | tACS or multisensory stimulation (device-based, active or sham) | Speech-language therapy (standard supportive care) |
|---|---|---|
| What it is | Device-based approach using transcranial alternating current stimulation (tACS), combined with light and/or sound flickers, either active or sham, aiming to modulate brain activity in PPA or MCI. | Noninvasive speech-language therapy and supportive care for adults with PPA or MCI, addressing language deficits through rehabilitation strategies, as recommended in recent consensus guidelines. |
| Primary use | Investigational stimulation intended to increase short-term memory capacity and assess changes in verbal tasks before and after device use. | Improvement and maintenance of language abilities through tailored rehabilitation, compensatory strategies, and communication support. |
| Important limitations | Device is investigational, with limited participant numbers and no established long-term safety or efficacy in PPA/MCI. Device use may be contraindicated in patients with implants, cardiac conditions, or seizure history, and results may not generalize to all populations. | Speech-language therapy requires regular sessions and active participant engagement. Benefits can vary and do not slow disease progression; access may be limited by resources or geographic factors. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Multiple sessions over the study period
Participants receive transcranial alternating current stimulation (tACS) and multisensory stimulation in multiple sessions. Active and sham tACS are delivered using electrodes placed at frontal and temporoparietal brain sites, with stimulation lasting about 20 minutes. Multisensory stimulation involves light and sound flicker using an app for 20 minutes.
Sessions scheduled based on study protocol
Duration - Throughout the study period
Participants complete EEG and MRI scans, cognitive exams, and language tasks before, during, and after stimulation sessions to measure changes in verbal short-term memory.
Multiple visits for imaging and cognitive testing
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jiaying Hu, Leyan Zheng, Ziyu Guan...
https://pubmed.ncbi.nlm.nih.gov/37625524/Hunter F Iaccarino, Annabelle C Singer, Anthony J Martorell...
https://pubmed.ncbi.nlm.nih.gov/27929004/Yi Tang, Yi Xing, Liwei Sun...
https://pubmed.ncbi.nlm.nih.gov/39267112/Sienna D McNett, Andrey Vyshedskiy, Andrei Savchenko...
https://pubmed.ncbi.nlm.nih.gov/37510481/Anthony J Martorell, Abigail L Paulson, Ho-Jun Suk...
https://pubmed.ncbi.nlm.nih.gov/30879788/Daniele Altomare, Alberto Benussi, Valentina Cantoni...
https://pubmed.ncbi.nlm.nih.gov/37715232/Medical College of Wisconsin
Lead Sponsor